Clinical Trials

30 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05914753 2023-06-22

Evaluating Xihuang Pill to Improve the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer

Breast Neoplasms

NCT05681728 2023-01-12

A Phase II Study Evaluating the Efficacy and Safety of Pembrolizumab in Combination With Chemotherapy as Neoadjuvant Therapy for Triple-negative Breast Cancer

26 enrolled

Breast Neoplasms

NCT05656079 2022-12-19

easy laugh

204 enrolled

Breast Neoplasms

NCT02752815 2022-12-05

Reduced Chemotherapy in Low Risk DLBCL

Phase 4 Unknown

290 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT05547516 2022-09-21

BL-PDT-RCT

140 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT05491694 2022-08-08

HIFU

20 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05483439 2022-08-05

A Study of Immunotherapy Combined With Neoadjuvant Therapy Versus Neoadjuvant Therapy for Breast Cancer

Breast Neoplasms

NCT05472896 2022-07-25

TACE With Dicycloplatin(TP21) in Unresectable HCC

332 enrolled

Carcinoma, Hepatocellular

NCT05400993 2022-06-06

Clinical Study of Chidamide Combined With Chemotherapy in Neoadjuvant Treatment of HR+/ HER2-BC

59 enrolled

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

130 enrolled

Breast Neoplasms

NCT04490993 2022-02-22

ACCRUE

359 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04736394 2022-02-22

ASCERTAIN

800 enrolled

Non-Muscle Invasive Bladder Neoplasms

NCT04771871 2022-02-18

TARMAC

42 enrolled

Breast Neoplasms, Neoplastic Cells, Circulating, Triple Negative Breast Neoplasms

NCT05121350 2022-02-18

A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

256 enrolled

Sarcoma

NCT05204524 2022-01-24

Temozolomide for Injection Combined With Epirubicin in First-line Treatment of Leiomyosarcoma

28 enrolled

Sarcoma

Leiomyosarcoma

NCT05146635 2022-01-11

Optimal Adjuvant Intravesical Therapy for Intermediate Risk Non Muscle Invasive Bladder Cancer: A Randomized Controlled Trial

110 enrolled

Urinary Bladder Neoplasms, Recurrence, Disease Progression

NCT05053386 2021-09-22

Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

186 enrolled

Carcinoma, Hepatocellular

NCT04717531 2021-06-04

Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer

60 enrolled

Breast Neoplasms

NCT04738188 2021-02-04

Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;

226 enrolled

Carcinoma, Hepatocellular

NCT04676997 2020-12-21

Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)

20 enrolled

Triple Negative Breast Neoplasms

NCT04498793 2020-09-03

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

55 enrolled

HER2-negative Breast Cancer

NCT02971345 2020-06-11

Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus

253 enrolled

Carcinoma, Hepatocellular

NCT02879513 2020-03-23

Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy

290 enrolled

Carcinoma, Ductal, Breast, Inflammatory Breast Neoplasms

NCT04255056 2020-02-07

PRETTY

27 enrolled

Breast Neoplasms

NCT04213898 2019-12-30

SHR-1210 Combined With Albumin-bound Paclitaxel and Epirubicin Neoadjuvant for Triple Negative Breast Cancer

Phase 1/2 Unknown

39 enrolled

Triple Negative Breast Neoplasms

NCT04061772 2019-08-20

A Study of Bortezomib Combined With CHEP in Peripheral T Cell Lymphoma

54 enrolled

Lymphoma, T-Cell, Peripheral

NCT01907529 2019-08-09

TENDENCY

300 enrolled

Breast Neoplasms

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Unknown

300 enrolled

Breast Cancer Organoids

NCT03123770 2019-04-10

ESNDBCP

Phase 4 Unknown

384 enrolled

Breast Neoplasms

NCT03876886 2019-03-21

The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency

Triple Negative Breast Neoplasms

NCT02177552 2019-02-15

SEED

98 enrolled

Esophageal Neoplasms, Stomach Neoplasms

NCT03755115 2019-01-16

SHR-1210 Combined With Epirubicin in the Treatment of Extensive Disease Small Cell Lung Cancer

40 enrolled

Thoracic

Small Cell Lung Cancer Extensive Stage

NCT03647280 2018-12-07

The Efficacy and Safety of Abraxane Combined With Epirubicin as Neoadjuvant Chemotherapy in Breast Cancer

50 enrolled

Breast Neoplasms

NCT03756090 2018-12-07

PECP

Breast Diseases, Breast Neoplasms

NCT03668418 2018-09-12

xenoZ

Unknown

120 enrolled

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00301925 2018-08-08

TACT2

4,400 enrolled

Breast Neoplasms, Breast Neoplasms, Male

NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Breast Diseases, Breast Neoplasms

NCT03349177 2017-11-21

Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy

Breast Neoplasms

NCT02694224 2017-10-24

SHH-CM

40 enrolled

Breast Neoplasms

NCT02760953 2017-10-19

TURBt With Adjuvant Cryoablation to Treat Bladder Cancer

150 enrolled

Urinary Bladder Neoplasms

NCT03273595 2017-09-06

Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive Breast Cancer

Breast Neoplasms

NCT02871869 2017-07-17

Cinobufacini Tablets Combined With Chemotherapeutic Protocol in Treatment of Diffuse Large B Cell Lymphoma

316 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01222052 2017-06-26

NNBC3-Europe

4,150 enrolled

Breast Neoplasms

NCT03192644 2017-06-20

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

162 enrolled

Carcinoma, Hepatocellular

NCT03006614 2017-01-16

PERS

320 enrolled

Breast Neoplasms

NCT03022123 2017-01-16

The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma

270 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT02987244 2016-12-08

Chidamide Plus CHOEP Combined With Upfront ASCT in Untreated Peripheral T-cell Lymphoma

Phase 1/2 Unknown

Lymphoma, T-Cell

NCT00450203 2016-12-01

ST03

1,103 enrolled